A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma.
Kato T, Tomiyama E, Koh Y, Matsushita M, Hayashi Y, Nakano K, Ishizuya YU, Wang C, Hatano K, Kawashima A, Ujike T, Kawasaki K, Morii E, Gotoh K, Eguchi H, Kiyotani K, Fujita K, Nonomura N, Uemura M.
Kato T, et al. Among authors: fujita k.
Anticancer Res. 2020 Sep;40(9):4875-4883. doi: 10.21873/anticanres.14490.
Anticancer Res. 2020.
PMID: 32878775